31 – 40 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al Reply
(
- Contribution to journal › Letter
- 2012
-
Mark
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
(
- Contribution to journal › Article
-
Mark
Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
ABO Blood Type Matching and Survival after Heart Transplantation: Analyze of the ISHLT Registry : Journal of Heart and Lung Transplantation
2012) 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 31(4, Suppl). p.136-136(
- Contribution to journal › Published meeting abstract
-
Mark
Influence of HLA Matching on Heart Transplant Outcomes
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2011
-
Mark
Long-term patient survival in ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
The prognostic value of BVAS and VDI in ANCA-AAV
2011) 15th International Vasculitis/ANCA Workshop In Clinical and Experimental Immunology 164(Suppl. 1). p.121-121(
- Contribution to journal › Published meeting abstract
-
Mark
A Model to Predict Cardiovascular Events in Patients With Newly Diagnosed Wegener's Granulomatosis and Microscopic Polyangiitis
(
- Contribution to journal › Article
-
Mark
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
(
- Contribution to journal › Article